Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

Clinical trial NCT01548378 · COMPLETED

Trial details

NCT number: NCT01548378
Sponsor: Beijing Northland Biotech. Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arterial Occlusive Disease Ulcers Ischemia Peripheral Vascular Disease

Start date: 2012-03-01
Primary completion: 2014-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.